Anthrax — Precision Vaccinations News

Clinical Trials

Fact checked by Robert Carlson, MD

May 3

2 min read

Therapeutic Anthrax Vaccine Candidate Launches Phase 3 Study

AV7909 vaccine is being developed for post-exposure prophylaxis of disease resulting from Bacillus anthracis exposure

microscope in a lab

Fact checked by Robert Carlson, MD

Jan 2

4 min read

3rd Generation Anthrax Vaccine Moves Forward

Emergent BioSolutions NuThrax anthrax vaccine adsorbed with CPG 7909 Adjuvant is being studied for use as a third-generation anthrax vaccine

New york city

Fact checked by Robert Carlson, MD

Dec 19

4 min read

Anthrax Vaccine BioThrax Expands Into Canada

Emergent BioSolutions anthrax vaccine BioThrax now approved for Canada

cows, bovines

Fact checked by Robert Carlson, MD

Oct 17

4 min read

Dual Protection Vaccine Candidate Against Anthrax & Plague Advances

T4 nanoparticle is a novel platform for developing multivalent vaccines against pathogens of high public health concern

army soldiers putting on gas masks

Fact checked by Robert Carlson, MD

Aug 21

6 min read

Anthrax Outbreak in Animals Near Southeastern France

Altimmune SparVax-L anthrax vaccine candidate showed positive comparison against BioThrax in preclinical study

cows in french pasture mountains in the background